Literature DB >> 19840250

Hepatic changes of erythropoietin gene expression in a rat model of acute-phase response.

Pierluigi Ramadori1, Nadeem Sheikh, Ghayyor Ahmad, Jozsef Dudas, Giuliano Ramadori.   

Abstract

An acute-phase response is the systemic reaction of an organism to insult (e.g. infection, trauma and burning). It represents the 'first line' of defence of the body to tissue-damaging attacks. In the present work, we used a rat model of an intra-muscular turpentine oil (TO) injection to analyse erythropoietin (EPO) gene expression changes in the liver, one of the main target organs of acute-phase cytokines. EPO began to increase in the serum of TO-treated animals 6 h after injection and reached a maximum at 24 h (125+/-20 pg/ml). The detection of total RNA by polymerase chain reaction analysis showed that the levels of EPO gene expression in the liver were considerably increased between 2 and 12 h by up to 20-fold at the peak after TO administration, followed by a gradual decrease over the next 48 h, although the values remained significantly higher compared with the control group. In the kidney, after a sudden slight increase, the values declined progressively to 3.5-fold decrease at 12 h after the injection. In the liver, a parallel upregulation of the hypoxia-inducible factor-1 (HIF-1) alpha gene was observed (up to 4.7-fold increase), while HIF-2 alpha gene expression remained unaltered. On the other hand, the protein of both genes became detectable after the injection and increased progressively over 24 h, with a subsequent decline. These results suggest that EPO may be added to the increasing group of positive acute-phase proteins and the liver might represent the major source of the hormone under these conditions in the rat.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19840250     DOI: 10.1111/j.1478-3231.2009.02131.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  7 in total

1.  Ionic imbalance, in addition to molecular crowding, abates cytoskeletal dynamics and vesicle motility during hypertonic stress.

Authors:  Paula Nunes; Isabelle Roth; Paolo Meda; Eric Féraille; Dennis Brown; Udo Hasler
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-04       Impact factor: 11.205

Review 2.  Nutritional and probiotic supplementation in colitis models.

Authors:  Radu M Nanau; Manuela G Neuman
Journal:  Dig Dis Sci       Date:  2012-06-27       Impact factor: 3.199

3.  Rat model of fractionated (2 Gy/day) 60 Gy irradiation of the liver: long-term effects.

Authors:  Margret Rave-Fränk; Ihtzaz Ahmed Malik; Hans Christiansen; Naila Naz; Sadaf Sultan; Ahmad Amanzada; Martina Blaschke; Silke Cameron; Shakil Ahmad; Clemens Friedrich Hess; Giuliano Ramadori; Federico Moriconi
Journal:  Radiat Environ Biophys       Date:  2013-04-18       Impact factor: 1.925

4.  Characterization of the erythropoietin/erythropoietin receptor axis in a rat model of liver damage and cholangiocarcinoma development.

Authors:  Federico Moriconi; Pierluigi Ramadori; Frank C Schultze; Martina Blaschke; Ahmad Amanzada; Sajjad Khan; Giuliano Ramadori
Journal:  Histochem Cell Biol       Date:  2012-10-04       Impact factor: 4.304

5.  Comparison of changes in gene expression of transferrin receptor-1 and other iron-regulatory proteins in rat liver and brain during acute-phase response.

Authors:  Ihtzaz Ahmed Malik; Naila Naz; Nadeem Sheikh; Sajjad Khan; Federico Moriconi; Martina Blaschke; Giuliano Ramadori
Journal:  Cell Tissue Res       Date:  2011-03-26       Impact factor: 5.249

6.  Clinical and pathological features of Nerium oleander extract toxicosis in wistar rats.

Authors:  Tasleem Akhtar; Nadeem Sheikh; Muddasir Hassan Abbasi
Journal:  BMC Res Notes       Date:  2014-12-23

7.  Erythropoietin enhances Kupffer cell number and activity in the challenged liver.

Authors:  Dafna Gilboa; Yasmin Haim-Ohana; Naamit Deshet-Unger; Nathalie Ben-Califa; Sahar Hiram-Bab; Debby Reuveni; Ehud Zigmond; Max Gassmann; Yankel Gabet; Chen Varol; Drorit Neumann
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.